prescribing guide semaglutide tirzepatide Avono Health | GLP-1 Explained: vs tirzepatide, broken down with the actual clinical trial data: how they work, weight loss, side effects, and Tirzepatide vs Semaglutide: Key Differences
Description
Adding 2 mL of bacteriostatic water to a 10 mg vial creates 5 mg/mL
TL;DR Tirzepatide is a dual GIP/GLP-1 receptor agonist manufactured by Eli Lilly, while semaglutide is a GLP-1 receptor agonist only, made by Novo Nordisk
The pharmacokinetics of tirzepatide after a single 5 mg dose was evaluated in patients with different degrees of hepatic impairment (mild, moderate, severe) compared with subjects with normal hepatic function [see Use in Specific Populations (8.7)]
Maintenance doses for compounded tirzepatide vary by pharmacy and individual provider protocol
